Accord Pharmaceuticals Recall March 2024. The recall is a precautionary measure due to the internal tablet blister strips being printed with an incorrect expiry date. Medac gmbh (t/a medac pharma llp), sodiofolin 50 mg/ml, solution for injection/infusion (folinic acid 400mg/8ml vial), el(24)a/08
On december 22, 2022, the u.s. Accord states the reason for the shortage is active ingredient delay.
Accord Did Not Provide A Reason For The Shortage.
Issues a nationwide voluntary recall of vancomycin hydrochloride for oral solution usp, 250mg/5ml, due to the potential for some bottles to be super potent.
Celebrating International Women's Day At Accord.
Voluntary recall of drug products manufactured at fei #.
Issues Nationwide Voluntary Recall Of Daptomycin For Injection 500 Mg/Vial And Daptomycin For Injection 350 Mg/Vial Lot # R2200232 Due.
Images References :
Accord States The Reason For The Shortage Is Active Ingredient Delay.
Is voluntarily recalling a single lot of daptomycin for injection 500 mg/vial, and daptomycin for injection 350 mg/vial product contained in.
Food And Drug Administration (Fda) Reported Accord Healthcare, Inc.โs, Voluntarily Recall Of A Single Lot Of Daptomycin For.